nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—CA2—osteoporosis	0.197	1	CbGaD
Furosemide—chronic kidney failure—Calcium Acetate—osteoporosis	0.176	0.416	CpDpCtD
Furosemide—chronic kidney failure—Calcitriol—osteoporosis	0.133	0.315	CpDpCtD
Furosemide—chronic kidney failure—Cholecalciferol—osteoporosis	0.113	0.268	CpDpCtD
Furosemide—CA14—Zoledronate—osteoporosis	0.0646	0.249	CbGbCtD
Furosemide—CA12—Zoledronate—osteoporosis	0.0459	0.177	CbGbCtD
Furosemide—CA2—Zoledronate—osteoporosis	0.0371	0.143	CbGbCtD
Furosemide—SLC22A11—Conjugated Estrogens—osteoporosis	0.0196	0.0755	CbGbCtD
Furosemide—SLC22A11—Estradiol—osteoporosis	0.0172	0.0663	CbGbCtD
Furosemide—ABCC2—Ethinyl Estradiol—osteoporosis	0.0148	0.0569	CbGbCtD
Furosemide—ALB—Estropipate—osteoporosis	0.0143	0.0551	CbGbCtD
Furosemide—SLC22A8—Conjugated Estrogens—osteoporosis	0.0114	0.0439	CbGbCtD
Furosemide—ABCC2—Conjugated Estrogens—osteoporosis	0.0108	0.0418	CbGbCtD
Furosemide—SLC22A8—Estradiol—osteoporosis	0.01	0.0385	CbGbCtD
Furosemide—SLC22A6—Conjugated Estrogens—osteoporosis	0.00794	0.0306	CbGbCtD
Furosemide—ALB—Estradiol—osteoporosis	0.00593	0.0229	CbGbCtD
Furosemide—Indapamide—CA2—osteoporosis	0.00101	1	CrCbGaD
Furosemide—Feeling abnormal—Ibandronate—osteoporosis	7.36e-05	0.00092	CcSEcCtD
Furosemide—Skin disorder—Ethinyl Estradiol—osteoporosis	7.33e-05	0.000917	CcSEcCtD
Furosemide—Hepatobiliary disease—Estradiol—osteoporosis	7.3e-05	0.000913	CcSEcCtD
Furosemide—Gastrointestinal pain—Ibandronate—osteoporosis	7.3e-05	0.000913	CcSEcCtD
Furosemide—Urticaria—Alendronate—osteoporosis	7.29e-05	0.000911	CcSEcCtD
Furosemide—Abdominal pain—Alendronate—osteoporosis	7.25e-05	0.000907	CcSEcCtD
Furosemide—Body temperature increased—Alendronate—osteoporosis	7.25e-05	0.000907	CcSEcCtD
Furosemide—Muscle spasms—Conjugated Estrogens—osteoporosis	7.25e-05	0.000907	CcSEcCtD
Furosemide—Shock—Risedronate—osteoporosis	7.24e-05	0.000906	CcSEcCtD
Furosemide—Anaemia—Zoledronate—osteoporosis	7.24e-05	0.000905	CcSEcCtD
Furosemide—Nervous system disorder—Risedronate—osteoporosis	7.22e-05	0.000903	CcSEcCtD
Furosemide—Agitation—Zoledronate—osteoporosis	7.2e-05	0.0009	CcSEcCtD
Furosemide—Skin disorder—Risedronate—osteoporosis	7.15e-05	0.000894	CcSEcCtD
Furosemide—Gastrointestinal pain—Calcitriol—osteoporosis	7.15e-05	0.000894	CcSEcCtD
Furosemide—Body temperature increased—Raloxifene—osteoporosis	7.13e-05	0.000892	CcSEcCtD
Furosemide—Abdominal pain—Raloxifene—osteoporosis	7.13e-05	0.000892	CcSEcCtD
Furosemide—Vision blurred—Conjugated Estrogens—osteoporosis	7.11e-05	0.000889	CcSEcCtD
Furosemide—Urticaria—Ibandronate—osteoporosis	7.09e-05	0.000887	CcSEcCtD
Furosemide—Abdominal pain—Ibandronate—osteoporosis	7.06e-05	0.000883	CcSEcCtD
Furosemide—Body temperature increased—Ibandronate—osteoporosis	7.06e-05	0.000883	CcSEcCtD
Furosemide—Confusional state—Pamidronate—osteoporosis	7.05e-05	0.000882	CcSEcCtD
Furosemide—Vertigo—Zoledronate—osteoporosis	7.03e-05	0.00088	CcSEcCtD
Furosemide—Leukopenia—Zoledronate—osteoporosis	7.01e-05	0.000877	CcSEcCtD
Furosemide—Anaphylactic shock—Pamidronate—osteoporosis	7e-05	0.000875	CcSEcCtD
Furosemide—Urticaria—Calcitriol—osteoporosis	6.94e-05	0.000869	CcSEcCtD
Furosemide—Body temperature increased—Calcitriol—osteoporosis	6.91e-05	0.000864	CcSEcCtD
Furosemide—Abdominal pain—Calcitriol—osteoporosis	6.91e-05	0.000864	CcSEcCtD
Furosemide—Shock—Pamidronate—osteoporosis	6.88e-05	0.000861	CcSEcCtD
Furosemide—Hypersensitivity—Estropipate—osteoporosis	6.86e-05	0.000858	CcSEcCtD
Furosemide—Nervous system disorder—Pamidronate—osteoporosis	6.86e-05	0.000858	CcSEcCtD
Furosemide—Thrombocytopenia—Pamidronate—osteoporosis	6.85e-05	0.000857	CcSEcCtD
Furosemide—Urinary tract disorder—Estradiol—osteoporosis	6.85e-05	0.000856	CcSEcCtD
Furosemide—Vomiting—Etidronic acid—osteoporosis	6.84e-05	0.000856	CcSEcCtD
Furosemide—Urethral disorder—Estradiol—osteoporosis	6.79e-05	0.00085	CcSEcCtD
Furosemide—Rash—Etidronic acid—osteoporosis	6.79e-05	0.000849	CcSEcCtD
Furosemide—Dermatitis—Etidronic acid—osteoporosis	6.78e-05	0.000848	CcSEcCtD
Furosemide—Vertigo—Conjugated Estrogens—osteoporosis	6.77e-05	0.000847	CcSEcCtD
Furosemide—Hyperhidrosis—Pamidronate—osteoporosis	6.76e-05	0.000846	CcSEcCtD
Furosemide—Hypersensitivity—Alendronate—osteoporosis	6.76e-05	0.000845	CcSEcCtD
Furosemide—Headache—Etidronic acid—osteoporosis	6.74e-05	0.000843	CcSEcCtD
Furosemide—Asthenia—Estropipate—osteoporosis	6.68e-05	0.000836	CcSEcCtD
Furosemide—Visual impairment—Estradiol—osteoporosis	6.68e-05	0.000836	CcSEcCtD
Furosemide—Anorexia—Pamidronate—osteoporosis	6.67e-05	0.000834	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	6.62e-05	0.000828	CcSEcCtD
Furosemide—Paraesthesia—Risedronate—osteoporosis	6.61e-05	0.000827	CcSEcCtD
Furosemide—Pruritus—Estropipate—osteoporosis	6.59e-05	0.000824	CcSEcCtD
Furosemide—Asthenia—Alendronate—osteoporosis	6.58e-05	0.000823	CcSEcCtD
Furosemide—Hypersensitivity—Ibandronate—osteoporosis	6.58e-05	0.000823	CcSEcCtD
Furosemide—Erythema multiforme—Estradiol—osteoporosis	6.55e-05	0.00082	CcSEcCtD
Furosemide—Hypotension—Pamidronate—osteoporosis	6.54e-05	0.000818	CcSEcCtD
Furosemide—Dry mouth—Zoledronate—osteoporosis	6.52e-05	0.000815	CcSEcCtD
Furosemide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	6.52e-05	0.000815	CcSEcCtD
Furosemide—Fatigue—Ethinyl Estradiol—osteoporosis	6.51e-05	0.000814	CcSEcCtD
Furosemide—Pruritus—Alendronate—osteoporosis	6.49e-05	0.000812	CcSEcCtD
Furosemide—Eye disorder—Estradiol—osteoporosis	6.48e-05	0.00081	CcSEcCtD
Furosemide—Tinnitus—Estradiol—osteoporosis	6.46e-05	0.000808	CcSEcCtD
Furosemide—Constipation—Ethinyl Estradiol—osteoporosis	6.45e-05	0.000807	CcSEcCtD
Furosemide—Confusional state—Zoledronate—osteoporosis	6.44e-05	0.000806	CcSEcCtD
Furosemide—Hypersensitivity—Calcitriol—osteoporosis	6.44e-05	0.000806	CcSEcCtD
Furosemide—Asthenia—Ibandronate—osteoporosis	6.41e-05	0.000801	CcSEcCtD
Furosemide—Nausea—Etidronic acid—osteoporosis	6.39e-05	0.0008	CcSEcCtD
Furosemide—Anaphylactic shock—Zoledronate—osteoporosis	6.39e-05	0.000799	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	6.37e-05	0.000797	CcSEcCtD
Furosemide—Diarrhoea—Estropipate—osteoporosis	6.37e-05	0.000797	CcSEcCtD
Furosemide—Gastrointestinal disorder—Risedronate—osteoporosis	6.35e-05	0.000795	CcSEcCtD
Furosemide—Fatigue—Risedronate—osteoporosis	6.34e-05	0.000794	CcSEcCtD
Furosemide—Pruritus—Ibandronate—osteoporosis	6.32e-05	0.00079	CcSEcCtD
Furosemide—Constipation—Risedronate—osteoporosis	6.29e-05	0.000787	CcSEcCtD
Furosemide—Pain—Risedronate—osteoporosis	6.29e-05	0.000787	CcSEcCtD
Furosemide—Angiopathy—Estradiol—osteoporosis	6.29e-05	0.000787	CcSEcCtD
Furosemide—Shock—Zoledronate—osteoporosis	6.29e-05	0.000786	CcSEcCtD
Furosemide—Paraesthesia—Pamidronate—osteoporosis	6.28e-05	0.000786	CcSEcCtD
Furosemide—Diarrhoea—Alendronate—osteoporosis	6.28e-05	0.000785	CcSEcCtD
Furosemide—Asthenia—Calcitriol—osteoporosis	6.27e-05	0.000785	CcSEcCtD
Furosemide—Nervous system disorder—Zoledronate—osteoporosis	6.27e-05	0.000784	CcSEcCtD
Furosemide—Immune system disorder—Estradiol—osteoporosis	6.26e-05	0.000783	CcSEcCtD
Furosemide—Thrombocytopenia—Zoledronate—osteoporosis	6.26e-05	0.000783	CcSEcCtD
Furosemide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	6.22e-05	0.000778	CcSEcCtD
Furosemide—Somnolence—Pamidronate—osteoporosis	6.22e-05	0.000778	CcSEcCtD
Furosemide—Skin disorder—Zoledronate—osteoporosis	6.21e-05	0.000776	CcSEcCtD
Furosemide—Pruritus—Calcitriol—osteoporosis	6.18e-05	0.000774	CcSEcCtD
Furosemide—Hyperhidrosis—Zoledronate—osteoporosis	6.18e-05	0.000773	CcSEcCtD
Furosemide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	6.17e-05	0.000772	CcSEcCtD
Furosemide—Diarrhoea—Raloxifene—osteoporosis	6.17e-05	0.000772	CcSEcCtD
Furosemide—Dizziness—Estropipate—osteoporosis	6.16e-05	0.00077	CcSEcCtD
Furosemide—Anaphylactic shock—Conjugated Estrogens—osteoporosis	6.15e-05	0.00077	CcSEcCtD
Furosemide—Diarrhoea—Ibandronate—osteoporosis	6.11e-05	0.000764	CcSEcCtD
Furosemide—Anorexia—Zoledronate—osteoporosis	6.09e-05	0.000762	CcSEcCtD
Furosemide—Decreased appetite—Pamidronate—osteoporosis	6.08e-05	0.000761	CcSEcCtD
Furosemide—Dizziness—Alendronate—osteoporosis	6.07e-05	0.000759	CcSEcCtD
Furosemide—Shock—Conjugated Estrogens—osteoporosis	6.05e-05	0.000757	CcSEcCtD
Furosemide—Gastrointestinal disorder—Pamidronate—osteoporosis	6.04e-05	0.000755	CcSEcCtD
Furosemide—Nervous system disorder—Conjugated Estrogens—osteoporosis	6.03e-05	0.000755	CcSEcCtD
Furosemide—Erythema—Estradiol—osteoporosis	6.03e-05	0.000755	CcSEcCtD
Furosemide—Malnutrition—Estradiol—osteoporosis	6.03e-05	0.000755	CcSEcCtD
Furosemide—Fatigue—Pamidronate—osteoporosis	6.03e-05	0.000754	CcSEcCtD
Furosemide—Gastrointestinal pain—Risedronate—osteoporosis	6.02e-05	0.000753	CcSEcCtD
Furosemide—Urticaria—Ethinyl Estradiol—osteoporosis	6e-05	0.00075	CcSEcCtD
Furosemide—Pain—Pamidronate—osteoporosis	5.98e-05	0.000748	CcSEcCtD
Furosemide—Constipation—Pamidronate—osteoporosis	5.98e-05	0.000748	CcSEcCtD
Furosemide—Diarrhoea—Calcitriol—osteoporosis	5.98e-05	0.000748	CcSEcCtD
Furosemide—Skin disorder—Conjugated Estrogens—osteoporosis	5.98e-05	0.000748	CcSEcCtD
Furosemide—Hypotension—Zoledronate—osteoporosis	5.97e-05	0.000747	CcSEcCtD
Furosemide—Abdominal pain—Ethinyl Estradiol—osteoporosis	5.97e-05	0.000746	CcSEcCtD
Furosemide—Body temperature increased—Ethinyl Estradiol—osteoporosis	5.97e-05	0.000746	CcSEcCtD
Furosemide—Dizziness—Raloxifene—osteoporosis	5.96e-05	0.000746	CcSEcCtD
Furosemide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	5.95e-05	0.000744	CcSEcCtD
Furosemide—Flatulence—Estradiol—osteoporosis	5.95e-05	0.000744	CcSEcCtD
Furosemide—Vomiting—Estropipate—osteoporosis	5.92e-05	0.000741	CcSEcCtD
Furosemide—Dysgeusia—Estradiol—osteoporosis	5.91e-05	0.000739	CcSEcCtD
Furosemide—Dizziness—Ibandronate—osteoporosis	5.91e-05	0.000739	CcSEcCtD
Furosemide—Rash—Estropipate—osteoporosis	5.87e-05	0.000734	CcSEcCtD
Furosemide—Dermatitis—Estropipate—osteoporosis	5.87e-05	0.000734	CcSEcCtD
Furosemide—Anorexia—Conjugated Estrogens—osteoporosis	5.87e-05	0.000734	CcSEcCtD
Furosemide—Urticaria—Risedronate—osteoporosis	5.85e-05	0.000731	CcSEcCtD
Furosemide—Headache—Estropipate—osteoporosis	5.83e-05	0.00073	CcSEcCtD
Furosemide—Vomiting—Alendronate—osteoporosis	5.83e-05	0.000729	CcSEcCtD
Furosemide—Body temperature increased—Risedronate—osteoporosis	5.82e-05	0.000728	CcSEcCtD
Furosemide—Abdominal pain—Risedronate—osteoporosis	5.82e-05	0.000728	CcSEcCtD
Furosemide—Muscle spasms—Estradiol—osteoporosis	5.8e-05	0.000726	CcSEcCtD
Furosemide—Rash—Alendronate—osteoporosis	5.78e-05	0.000723	CcSEcCtD
Furosemide—Dermatitis—Alendronate—osteoporosis	5.78e-05	0.000723	CcSEcCtD
Furosemide—Feeling abnormal—Pamidronate—osteoporosis	5.77e-05	0.000721	CcSEcCtD
Furosemide—Hypotension—Conjugated Estrogens—osteoporosis	5.75e-05	0.000719	CcSEcCtD
Furosemide—Headache—Alendronate—osteoporosis	5.75e-05	0.000719	CcSEcCtD
Furosemide—Paraesthesia—Zoledronate—osteoporosis	5.74e-05	0.000718	CcSEcCtD
Furosemide—Vomiting—Raloxifene—osteoporosis	5.74e-05	0.000717	CcSEcCtD
Furosemide—Gastrointestinal pain—Pamidronate—osteoporosis	5.72e-05	0.000716	CcSEcCtD
Furosemide—Rash—Raloxifene—osteoporosis	5.69e-05	0.000711	CcSEcCtD
Furosemide—Dermatitis—Raloxifene—osteoporosis	5.68e-05	0.000711	CcSEcCtD
Furosemide—Somnolence—Zoledronate—osteoporosis	5.68e-05	0.000711	CcSEcCtD
Furosemide—Vomiting—Ibandronate—osteoporosis	5.68e-05	0.00071	CcSEcCtD
Furosemide—Headache—Raloxifene—osteoporosis	5.65e-05	0.000707	CcSEcCtD
Furosemide—Rash—Ibandronate—osteoporosis	5.63e-05	0.000704	CcSEcCtD
Furosemide—Dermatitis—Ibandronate—osteoporosis	5.63e-05	0.000704	CcSEcCtD
Furosemide—Headache—Ibandronate—osteoporosis	5.59e-05	0.0007	CcSEcCtD
Furosemide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	5.56e-05	0.000696	CcSEcCtD
Furosemide—Vomiting—Calcitriol—osteoporosis	5.56e-05	0.000695	CcSEcCtD
Furosemide—Decreased appetite—Zoledronate—osteoporosis	5.56e-05	0.000695	CcSEcCtD
Furosemide—Agitation—Estradiol—osteoporosis	5.55e-05	0.000694	CcSEcCtD
Furosemide—Nausea—Estropipate—osteoporosis	5.53e-05	0.000692	CcSEcCtD
Furosemide—Abdominal pain—Pamidronate—osteoporosis	5.53e-05	0.000692	CcSEcCtD
Furosemide—Body temperature increased—Pamidronate—osteoporosis	5.53e-05	0.000692	CcSEcCtD
Furosemide—Paraesthesia—Conjugated Estrogens—osteoporosis	5.53e-05	0.000691	CcSEcCtD
Furosemide—Gastrointestinal disorder—Zoledronate—osteoporosis	5.52e-05	0.00069	CcSEcCtD
Furosemide—Rash—Calcitriol—osteoporosis	5.51e-05	0.000689	CcSEcCtD
Furosemide—Fatigue—Zoledronate—osteoporosis	5.51e-05	0.000689	CcSEcCtD
Furosemide—Dermatitis—Calcitriol—osteoporosis	5.51e-05	0.000689	CcSEcCtD
Furosemide—Headache—Calcitriol—osteoporosis	5.48e-05	0.000685	CcSEcCtD
Furosemide—Somnolence—Conjugated Estrogens—osteoporosis	5.47e-05	0.000684	CcSEcCtD
Furosemide—Pain—Zoledronate—osteoporosis	5.46e-05	0.000684	CcSEcCtD
Furosemide—Constipation—Zoledronate—osteoporosis	5.46e-05	0.000684	CcSEcCtD
Furosemide—Nausea—Alendronate—osteoporosis	5.45e-05	0.000681	CcSEcCtD
Furosemide—Hypersensitivity—Risedronate—osteoporosis	5.42e-05	0.000678	CcSEcCtD
Furosemide—Vertigo—Estradiol—osteoporosis	5.42e-05	0.000678	CcSEcCtD
Furosemide—Asthenia—Ethinyl Estradiol—osteoporosis	5.42e-05	0.000677	CcSEcCtD
Furosemide—Nausea—Raloxifene—osteoporosis	5.36e-05	0.00067	CcSEcCtD
Furosemide—Decreased appetite—Conjugated Estrogens—osteoporosis	5.35e-05	0.000669	CcSEcCtD
Furosemide—Pruritus—Ethinyl Estradiol—osteoporosis	5.34e-05	0.000668	CcSEcCtD
Furosemide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	5.31e-05	0.000664	CcSEcCtD
Furosemide—Fatigue—Conjugated Estrogens—osteoporosis	5.3e-05	0.000664	CcSEcCtD
Furosemide—Nausea—Ibandronate—osteoporosis	5.3e-05	0.000663	CcSEcCtD
Furosemide—Asthenia—Risedronate—osteoporosis	5.28e-05	0.00066	CcSEcCtD
Furosemide—Feeling abnormal—Zoledronate—osteoporosis	5.27e-05	0.000659	CcSEcCtD
Furosemide—Pain—Conjugated Estrogens—osteoporosis	5.26e-05	0.000658	CcSEcCtD
Furosemide—Constipation—Conjugated Estrogens—osteoporosis	5.26e-05	0.000658	CcSEcCtD
Furosemide—Gastrointestinal pain—Zoledronate—osteoporosis	5.23e-05	0.000654	CcSEcCtD
Furosemide—Pruritus—Risedronate—osteoporosis	5.21e-05	0.000651	CcSEcCtD
Furosemide—Nausea—Calcitriol—osteoporosis	5.19e-05	0.000649	CcSEcCtD
Furosemide—Diarrhoea—Ethinyl Estradiol—osteoporosis	5.16e-05	0.000646	CcSEcCtD
Furosemide—Hypersensitivity—Pamidronate—osteoporosis	5.15e-05	0.000645	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	5.1e-05	0.000638	CcSEcCtD
Furosemide—Urticaria—Zoledronate—osteoporosis	5.08e-05	0.000635	CcSEcCtD
Furosemide—Abdominal pain—Zoledronate—osteoporosis	5.05e-05	0.000632	CcSEcCtD
Furosemide—Body temperature increased—Zoledronate—osteoporosis	5.05e-05	0.000632	CcSEcCtD
Furosemide—Diarrhoea—Risedronate—osteoporosis	5.04e-05	0.00063	CcSEcCtD
Furosemide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	5.03e-05	0.000629	CcSEcCtD
Furosemide—Dry mouth—Estradiol—osteoporosis	5.02e-05	0.000628	CcSEcCtD
Furosemide—Asthenia—Pamidronate—osteoporosis	5.02e-05	0.000628	CcSEcCtD
Furosemide—Dizziness—Ethinyl Estradiol—osteoporosis	4.99e-05	0.000624	CcSEcCtD
Furosemide—Confusional state—Estradiol—osteoporosis	4.97e-05	0.000621	CcSEcCtD
Furosemide—Pruritus—Pamidronate—osteoporosis	4.95e-05	0.000619	CcSEcCtD
Furosemide—Anaphylactic shock—Estradiol—osteoporosis	4.92e-05	0.000616	CcSEcCtD
Furosemide—Urticaria—Conjugated Estrogens—osteoporosis	4.89e-05	0.000611	CcSEcCtD
Furosemide—Dizziness—Risedronate—osteoporosis	4.87e-05	0.000609	CcSEcCtD
Furosemide—Body temperature increased—Conjugated Estrogens—osteoporosis	4.86e-05	0.000608	CcSEcCtD
Furosemide—Abdominal pain—Conjugated Estrogens—osteoporosis	4.86e-05	0.000608	CcSEcCtD
Furosemide—Shock—Estradiol—osteoporosis	4.84e-05	0.000606	CcSEcCtD
Furosemide—Nervous system disorder—Estradiol—osteoporosis	4.83e-05	0.000604	CcSEcCtD
Furosemide—Vomiting—Ethinyl Estradiol—osteoporosis	4.8e-05	0.0006	CcSEcCtD
Furosemide—Diarrhoea—Pamidronate—osteoporosis	4.79e-05	0.000599	CcSEcCtD
Furosemide—Skin disorder—Estradiol—osteoporosis	4.78e-05	0.000598	CcSEcCtD
Furosemide—Hyperhidrosis—Estradiol—osteoporosis	4.76e-05	0.000595	CcSEcCtD
Furosemide—Rash—Ethinyl Estradiol—osteoporosis	4.76e-05	0.000595	CcSEcCtD
Furosemide—Dermatitis—Ethinyl Estradiol—osteoporosis	4.75e-05	0.000595	CcSEcCtD
Furosemide—Headache—Ethinyl Estradiol—osteoporosis	4.73e-05	0.000591	CcSEcCtD
Furosemide—Hypersensitivity—Zoledronate—osteoporosis	4.71e-05	0.000589	CcSEcCtD
Furosemide—Vomiting—Risedronate—osteoporosis	4.68e-05	0.000585	CcSEcCtD
Furosemide—Rash—Risedronate—osteoporosis	4.64e-05	0.00058	CcSEcCtD
Furosemide—Dermatitis—Risedronate—osteoporosis	4.64e-05	0.00058	CcSEcCtD
Furosemide—Dizziness—Pamidronate—osteoporosis	4.63e-05	0.000579	CcSEcCtD
Furosemide—Headache—Risedronate—osteoporosis	4.61e-05	0.000577	CcSEcCtD
Furosemide—Asthenia—Zoledronate—osteoporosis	4.58e-05	0.000573	CcSEcCtD
Furosemide—Hypersensitivity—Conjugated Estrogens—osteoporosis	4.53e-05	0.000567	CcSEcCtD
Furosemide—Pruritus—Zoledronate—osteoporosis	4.52e-05	0.000566	CcSEcCtD
Furosemide—Nausea—Ethinyl Estradiol—osteoporosis	4.48e-05	0.000561	CcSEcCtD
Furosemide—Vomiting—Pamidronate—osteoporosis	4.45e-05	0.000556	CcSEcCtD
Furosemide—Paraesthesia—Estradiol—osteoporosis	4.42e-05	0.000553	CcSEcCtD
Furosemide—Asthenia—Conjugated Estrogens—osteoporosis	4.41e-05	0.000552	CcSEcCtD
Furosemide—Rash—Pamidronate—osteoporosis	4.41e-05	0.000552	CcSEcCtD
Furosemide—Dermatitis—Pamidronate—osteoporosis	4.41e-05	0.000551	CcSEcCtD
Furosemide—Headache—Pamidronate—osteoporosis	4.38e-05	0.000548	CcSEcCtD
Furosemide—Somnolence—Estradiol—osteoporosis	4.38e-05	0.000548	CcSEcCtD
Furosemide—Diarrhoea—Zoledronate—osteoporosis	4.37e-05	0.000547	CcSEcCtD
Furosemide—Nausea—Risedronate—osteoporosis	4.37e-05	0.000547	CcSEcCtD
Furosemide—Pruritus—Conjugated Estrogens—osteoporosis	4.35e-05	0.000545	CcSEcCtD
Furosemide—Decreased appetite—Estradiol—osteoporosis	4.28e-05	0.000535	CcSEcCtD
Furosemide—Gastrointestinal disorder—Estradiol—osteoporosis	4.25e-05	0.000532	CcSEcCtD
Furosemide—Fatigue—Estradiol—osteoporosis	4.25e-05	0.000531	CcSEcCtD
Furosemide—Dizziness—Zoledronate—osteoporosis	4.23e-05	0.000529	CcSEcCtD
Furosemide—Pain—Estradiol—osteoporosis	4.21e-05	0.000527	CcSEcCtD
Furosemide—Constipation—Estradiol—osteoporosis	4.21e-05	0.000527	CcSEcCtD
Furosemide—Diarrhoea—Conjugated Estrogens—osteoporosis	4.21e-05	0.000527	CcSEcCtD
Furosemide—Nausea—Pamidronate—osteoporosis	4.16e-05	0.00052	CcSEcCtD
Furosemide—Dizziness—Conjugated Estrogens—osteoporosis	4.07e-05	0.000509	CcSEcCtD
Furosemide—Vomiting—Zoledronate—osteoporosis	4.06e-05	0.000508	CcSEcCtD
Furosemide—Feeling abnormal—Estradiol—osteoporosis	4.06e-05	0.000508	CcSEcCtD
Furosemide—Rash—Zoledronate—osteoporosis	4.03e-05	0.000504	CcSEcCtD
Furosemide—Gastrointestinal pain—Estradiol—osteoporosis	4.03e-05	0.000504	CcSEcCtD
Furosemide—Dermatitis—Zoledronate—osteoporosis	4.03e-05	0.000504	CcSEcCtD
Furosemide—Headache—Zoledronate—osteoporosis	4e-05	0.000501	CcSEcCtD
Furosemide—Vomiting—Conjugated Estrogens—osteoporosis	3.91e-05	0.000489	CcSEcCtD
Furosemide—Urticaria—Estradiol—osteoporosis	3.91e-05	0.000489	CcSEcCtD
Furosemide—Body temperature increased—Estradiol—osteoporosis	3.89e-05	0.000487	CcSEcCtD
Furosemide—Abdominal pain—Estradiol—osteoporosis	3.89e-05	0.000487	CcSEcCtD
Furosemide—Rash—Conjugated Estrogens—osteoporosis	3.88e-05	0.000485	CcSEcCtD
Furosemide—Dermatitis—Conjugated Estrogens—osteoporosis	3.88e-05	0.000485	CcSEcCtD
Furosemide—Headache—Conjugated Estrogens—osteoporosis	3.85e-05	0.000482	CcSEcCtD
Furosemide—Nausea—Zoledronate—osteoporosis	3.8e-05	0.000475	CcSEcCtD
Furosemide—Nausea—Conjugated Estrogens—osteoporosis	3.65e-05	0.000457	CcSEcCtD
Furosemide—Hypersensitivity—Estradiol—osteoporosis	3.63e-05	0.000454	CcSEcCtD
Furosemide—Asthenia—Estradiol—osteoporosis	3.53e-05	0.000442	CcSEcCtD
Furosemide—Pruritus—Estradiol—osteoporosis	3.48e-05	0.000436	CcSEcCtD
Furosemide—Diarrhoea—Estradiol—osteoporosis	3.37e-05	0.000421	CcSEcCtD
Furosemide—Dizziness—Estradiol—osteoporosis	3.26e-05	0.000407	CcSEcCtD
Furosemide—Vomiting—Estradiol—osteoporosis	3.13e-05	0.000392	CcSEcCtD
Furosemide—Rash—Estradiol—osteoporosis	3.11e-05	0.000388	CcSEcCtD
Furosemide—Dermatitis—Estradiol—osteoporosis	3.1e-05	0.000388	CcSEcCtD
Furosemide—Headache—Estradiol—osteoporosis	3.09e-05	0.000386	CcSEcCtD
Furosemide—PGD—Disease—WNT1—osteoporosis	3.01e-05	0.000747	CbGpPWpGaD
Furosemide—PGD—Metabolism—TPI1—osteoporosis	3.01e-05	0.000746	CbGpPWpGaD
Furosemide—CA14—Metabolism—P4HB—osteoporosis	3.01e-05	0.000746	CbGpPWpGaD
Furosemide—CA12—Metabolism—CYP27A1—osteoporosis	2.99e-05	0.00074	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—MTHFR—osteoporosis	2.98e-05	0.000738	CbGpPWpGaD
Furosemide—CA4—Metabolism—MGLL—osteoporosis	2.98e-05	0.000738	CbGpPWpGaD
Furosemide—CA14—Metabolism—GAPDH—osteoporosis	2.96e-05	0.000732	CbGpPWpGaD
Furosemide—ALB—Hemostasis—WDR1—osteoporosis	2.95e-05	0.00073	CbGpPWpGaD
Furosemide—CA6—Metabolism—P4HB—osteoporosis	2.93e-05	0.000727	CbGpPWpGaD
Furosemide—CA5A—Metabolism—P4HB—osteoporosis	2.93e-05	0.000727	CbGpPWpGaD
Furosemide—PGD—Disease—FGA—osteoporosis	2.93e-05	0.000726	CbGpPWpGaD
Furosemide—CA2—Metabolism—OXCT1—osteoporosis	2.93e-05	0.000726	CbGpPWpGaD
Furosemide—Nausea—Estradiol—osteoporosis	2.93e-05	0.000366	CcSEcCtD
Furosemide—CA7—Metabolism—TPI1—osteoporosis	2.91e-05	0.000722	CbGpPWpGaD
Furosemide—CA5B—Metabolism—TPI1—osteoporosis	2.91e-05	0.000722	CbGpPWpGaD
Furosemide—CA12—Metabolism—ACP5—osteoporosis	2.9e-05	0.000719	CbGpPWpGaD
Furosemide—CA9—Metabolism—PNP—osteoporosis	2.9e-05	0.000719	CbGpPWpGaD
Furosemide—CA9—Metabolism—ATIC—osteoporosis	2.9e-05	0.000719	CbGpPWpGaD
Furosemide—CA6—Metabolism—GAPDH—osteoporosis	2.88e-05	0.000714	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GAPDH—osteoporosis	2.88e-05	0.000714	CbGpPWpGaD
Furosemide—CA14—Metabolism—RAP1A—osteoporosis	2.88e-05	0.000713	CbGpPWpGaD
Furosemide—CA2—Metabolism—MGLL—osteoporosis	2.86e-05	0.000707	CbGpPWpGaD
Furosemide—PGD—Metabolism—P4HB—osteoporosis	2.83e-05	0.000702	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	2.83e-05	0.000701	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ANXA2—osteoporosis	2.82e-05	0.000698	CbGpPWpGaD
Furosemide—CA1—Metabolism—CA2—osteoporosis	2.81e-05	0.000696	CbGpPWpGaD
Furosemide—CA1—Metabolism—OXCT1—osteoporosis	2.81e-05	0.000696	CbGpPWpGaD
Furosemide—CA6—Metabolism—RAP1A—osteoporosis	2.81e-05	0.000695	CbGpPWpGaD
Furosemide—CA5A—Metabolism—RAP1A—osteoporosis	2.81e-05	0.000695	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	2.79e-05	0.000692	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.78e-05	0.00069	CbGpPWpGaD
Furosemide—PGD—Metabolism—GAPDH—osteoporosis	2.78e-05	0.000689	CbGpPWpGaD
Furosemide—CA7—Metabolism—P4HB—osteoporosis	2.74e-05	0.000679	CbGpPWpGaD
Furosemide—CA5B—Metabolism—P4HB—osteoporosis	2.74e-05	0.000679	CbGpPWpGaD
Furosemide—CA1—Metabolism—MGLL—osteoporosis	2.74e-05	0.000678	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ANXA2—osteoporosis	2.73e-05	0.000677	CbGpPWpGaD
Furosemide—PGD—Metabolism—RAP1A—osteoporosis	2.71e-05	0.000671	CbGpPWpGaD
Furosemide—CA12—Metabolism—TPI1—osteoporosis	2.7e-05	0.000669	CbGpPWpGaD
Furosemide—CA7—Metabolism—GAPDH—osteoporosis	2.69e-05	0.000666	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GAPDH—osteoporosis	2.69e-05	0.000666	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	2.69e-05	0.000666	CbGpPWpGaD
Furosemide—CA5B—Metabolism—RAP1A—osteoporosis	2.62e-05	0.000649	CbGpPWpGaD
Furosemide—CA7—Metabolism—RAP1A—osteoporosis	2.62e-05	0.000649	CbGpPWpGaD
Furosemide—PGD—Disease—ENO1—osteoporosis	2.61e-05	0.000647	CbGpPWpGaD
Furosemide—PGD—Disease—PSMA2—osteoporosis	2.57e-05	0.000638	CbGpPWpGaD
Furosemide—PGD—Disease—PSMA5—osteoporosis	2.57e-05	0.000638	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	2.56e-05	0.000635	CbGpPWpGaD
Furosemide—CA12—Metabolism—P4HB—osteoporosis	2.54e-05	0.000629	CbGpPWpGaD
Furosemide—CA4—Metabolism—IDH2—osteoporosis	2.53e-05	0.000627	CbGpPWpGaD
Furosemide—CA12—Metabolism—GAPDH—osteoporosis	2.49e-05	0.000617	CbGpPWpGaD
Furosemide—CA9—Metabolism—OXCT1—osteoporosis	2.47e-05	0.000612	CbGpPWpGaD
Furosemide—CA9—Metabolism—CA2—osteoporosis	2.47e-05	0.000612	CbGpPWpGaD
Furosemide—CA2—Metabolism—IDH2—osteoporosis	2.43e-05	0.000601	CbGpPWpGaD
Furosemide—CA12—Metabolism—RAP1A—osteoporosis	2.43e-05	0.000601	CbGpPWpGaD
Furosemide—CA9—Metabolism—MGLL—osteoporosis	2.41e-05	0.000596	CbGpPWpGaD
Furosemide—PGD—Disease—CALCA—osteoporosis	2.4e-05	0.000594	CbGpPWpGaD
Furosemide—CA4—Metabolism—CYP27A1—osteoporosis	2.38e-05	0.00059	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	2.37e-05	0.000586	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	2.35e-05	0.000581	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	2.33e-05	0.000578	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CAP1—osteoporosis	2.33e-05	0.000577	CbGpPWpGaD
Furosemide—CA14—Metabolism—ENO1—osteoporosis	2.33e-05	0.000577	CbGpPWpGaD
Furosemide—CA1—Metabolism—IDH2—osteoporosis	2.33e-05	0.000577	CbGpPWpGaD
Furosemide—CA4—Metabolism—ACP5—osteoporosis	2.32e-05	0.000574	CbGpPWpGaD
Furosemide—CA14—Metabolism—PSMA2—osteoporosis	2.29e-05	0.000568	CbGpPWpGaD
Furosemide—CA14—Metabolism—PSMA5—osteoporosis	2.29e-05	0.000568	CbGpPWpGaD
Furosemide—CA2—Metabolism—CYP27A1—osteoporosis	2.28e-05	0.000565	CbGpPWpGaD
Furosemide—CA6—Metabolism—ENO1—osteoporosis	2.27e-05	0.000562	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ENO1—osteoporosis	2.27e-05	0.000562	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PSMA2—osteoporosis	2.23e-05	0.000554	CbGpPWpGaD
Furosemide—CA6—Metabolism—PSMA2—osteoporosis	2.23e-05	0.000554	CbGpPWpGaD
Furosemide—CA6—Metabolism—PSMA5—osteoporosis	2.23e-05	0.000554	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PSMA5—osteoporosis	2.23e-05	0.000554	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.22e-05	0.000551	CbGpPWpGaD
Furosemide—CA2—Metabolism—ACP5—osteoporosis	2.22e-05	0.00055	CbGpPWpGaD
Furosemide—PGD—Metabolism—ENO1—osteoporosis	2.19e-05	0.000542	CbGpPWpGaD
Furosemide—CA1—Metabolism—CYP27A1—osteoporosis	2.19e-05	0.000542	CbGpPWpGaD
Furosemide—PGD—Disease—KL—osteoporosis	2.18e-05	0.00054	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	2.17e-05	0.000538	CbGpPWpGaD
Furosemide—PGD—Metabolism—PSMA2—osteoporosis	2.16e-05	0.000534	CbGpPWpGaD
Furosemide—PGD—Metabolism—PSMA5—osteoporosis	2.16e-05	0.000534	CbGpPWpGaD
Furosemide—CA4—Metabolism—TPI1—osteoporosis	2.15e-05	0.000533	CbGpPWpGaD
Furosemide—CA1—Metabolism—ACP5—osteoporosis	2.13e-05	0.000527	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ENO1—osteoporosis	2.12e-05	0.000525	CbGpPWpGaD
Furosemide—CA7—Metabolism—ENO1—osteoporosis	2.12e-05	0.000525	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	2.12e-05	0.000524	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PSMA5—osteoporosis	2.09e-05	0.000517	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PSMA2—osteoporosis	2.09e-05	0.000517	CbGpPWpGaD
Furosemide—CA7—Metabolism—PSMA5—osteoporosis	2.09e-05	0.000517	CbGpPWpGaD
Furosemide—CA7—Metabolism—PSMA2—osteoporosis	2.09e-05	0.000517	CbGpPWpGaD
Furosemide—CA2—Metabolism—TPI1—osteoporosis	2.06e-05	0.000511	CbGpPWpGaD
Furosemide—CA9—Metabolism—IDH2—osteoporosis	2.05e-05	0.000507	CbGpPWpGaD
Furosemide—CA4—Metabolism—P4HB—osteoporosis	2.02e-05	0.000501	CbGpPWpGaD
Furosemide—CA4—Metabolism—GAPDH—osteoporosis	1.99e-05	0.000492	CbGpPWpGaD
Furosemide—CA1—Metabolism—TPI1—osteoporosis	1.98e-05	0.00049	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—IGF1—osteoporosis	1.97e-05	0.000487	CbGpPWpGaD
Furosemide—CA12—Metabolism—ENO1—osteoporosis	1.96e-05	0.000486	CbGpPWpGaD
Furosemide—CA2—Metabolism—P4HB—osteoporosis	1.94e-05	0.000481	CbGpPWpGaD
Furosemide—CA4—Metabolism—RAP1A—osteoporosis	1.94e-05	0.000479	CbGpPWpGaD
Furosemide—CA12—Metabolism—PSMA2—osteoporosis	1.93e-05	0.000479	CbGpPWpGaD
Furosemide—CA12—Metabolism—PSMA5—osteoporosis	1.93e-05	0.000479	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	1.93e-05	0.000477	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP27A1—osteoporosis	1.92e-05	0.000477	CbGpPWpGaD
Furosemide—CA2—Metabolism—GAPDH—osteoporosis	1.9e-05	0.000472	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	1.87e-05	0.000464	CbGpPWpGaD
Furosemide—CA9—Metabolism—ACP5—osteoporosis	1.87e-05	0.000464	CbGpPWpGaD
Furosemide—CA14—Metabolism—CYP19A1—osteoporosis	1.86e-05	0.000461	CbGpPWpGaD
Furosemide—CA1—Metabolism—P4HB—osteoporosis	1.86e-05	0.000461	CbGpPWpGaD
Furosemide—CA2—Metabolism—RAP1A—osteoporosis	1.86e-05	0.00046	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MGLL—osteoporosis	1.85e-05	0.000459	CbGpPWpGaD
Furosemide—CA1—Metabolism—GAPDH—osteoporosis	1.83e-05	0.000452	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CYP19A1—osteoporosis	1.81e-05	0.000449	CbGpPWpGaD
Furosemide—CA6—Metabolism—CYP19A1—osteoporosis	1.81e-05	0.000449	CbGpPWpGaD
Furosemide—CA1—Metabolism—RAP1A—osteoporosis	1.78e-05	0.000441	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL1B—osteoporosis	1.77e-05	0.000438	CbGpPWpGaD
Furosemide—PGD—Metabolism—CYP19A1—osteoporosis	1.75e-05	0.000433	CbGpPWpGaD
Furosemide—CA9—Metabolism—TPI1—osteoporosis	1.74e-05	0.000431	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.73e-05	0.000428	CbGpPWpGaD
Furosemide—PGD—Disease—ADCY5—osteoporosis	1.71e-05	0.000423	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLEK—osteoporosis	1.69e-05	0.000419	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ANXA2—osteoporosis	1.69e-05	0.000419	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CYP19A1—osteoporosis	1.69e-05	0.000419	CbGpPWpGaD
Furosemide—CA7—Metabolism—CYP19A1—osteoporosis	1.69e-05	0.000419	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.69e-05	0.000417	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.66e-05	0.000412	CbGpPWpGaD
Furosemide—CA9—Metabolism—P4HB—osteoporosis	1.64e-05	0.000405	CbGpPWpGaD
Furosemide—CA9—Metabolism—GAPDH—osteoporosis	1.61e-05	0.000398	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	1.58e-05	0.000391	CbGpPWpGaD
Furosemide—PGD—Disease—MTHFR—osteoporosis	1.57e-05	0.000389	CbGpPWpGaD
Furosemide—CA12—Metabolism—CYP19A1—osteoporosis	1.57e-05	0.000389	CbGpPWpGaD
Furosemide—CA4—Metabolism—ENO1—osteoporosis	1.56e-05	0.000388	CbGpPWpGaD
Furosemide—CA9—Metabolism—RAP1A—osteoporosis	1.56e-05	0.000387	CbGpPWpGaD
Furosemide—CA4—Metabolism—PSMA5—osteoporosis	1.54e-05	0.000382	CbGpPWpGaD
Furosemide—CA4—Metabolism—PSMA2—osteoporosis	1.54e-05	0.000382	CbGpPWpGaD
Furosemide—CA14—Metabolism—ADCY5—osteoporosis	1.52e-05	0.000377	CbGpPWpGaD
Furosemide—CA14—Metabolism—GPX1—osteoporosis	1.52e-05	0.000375	CbGpPWpGaD
Furosemide—CA2—Metabolism—ENO1—osteoporosis	1.5e-05	0.000372	CbGpPWpGaD
Furosemide—PGD—Disease—IRS2—osteoporosis	1.49e-05	0.00037	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ADCY5—osteoporosis	1.48e-05	0.000367	CbGpPWpGaD
Furosemide—CA6—Metabolism—ADCY5—osteoporosis	1.48e-05	0.000367	CbGpPWpGaD
Furosemide—CA2—Metabolism—PSMA2—osteoporosis	1.48e-05	0.000366	CbGpPWpGaD
Furosemide—CA2—Metabolism—PSMA5—osteoporosis	1.48e-05	0.000366	CbGpPWpGaD
Furosemide—CA6—Metabolism—GPX1—osteoporosis	1.48e-05	0.000366	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GPX1—osteoporosis	1.48e-05	0.000366	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.47e-05	0.000363	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TLN1—osteoporosis	1.46e-05	0.000361	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VCL—osteoporosis	1.44e-05	0.000357	CbGpPWpGaD
Furosemide—CA1—Metabolism—ENO1—osteoporosis	1.44e-05	0.000356	CbGpPWpGaD
Furosemide—PGD—Metabolism—ADCY5—osteoporosis	1.43e-05	0.000354	CbGpPWpGaD
Furosemide—PGD—Metabolism—GPX1—osteoporosis	1.42e-05	0.000353	CbGpPWpGaD
Furosemide—CA1—Metabolism—PSMA2—osteoporosis	1.42e-05	0.000351	CbGpPWpGaD
Furosemide—CA1—Metabolism—PSMA5—osteoporosis	1.42e-05	0.000351	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	1.4e-05	0.000348	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.4e-05	0.000347	CbGpPWpGaD
Furosemide—CA14—Metabolism—MTHFR—osteoporosis	1.4e-05	0.000346	CbGpPWpGaD
Furosemide—CA7—Metabolism—ADCY5—osteoporosis	1.38e-05	0.000343	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ADCY5—osteoporosis	1.38e-05	0.000343	CbGpPWpGaD
Furosemide—CA7—Metabolism—GPX1—osteoporosis	1.38e-05	0.000341	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GPX1—osteoporosis	1.38e-05	0.000341	CbGpPWpGaD
Furosemide—CA5A—Metabolism—MTHFR—osteoporosis	1.36e-05	0.000338	CbGpPWpGaD
Furosemide—CA6—Metabolism—MTHFR—osteoporosis	1.36e-05	0.000338	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—TGFB1—osteoporosis	1.36e-05	0.000336	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.35e-05	0.000334	CbGpPWpGaD
Furosemide—PGD—Metabolism—MTHFR—osteoporosis	1.31e-05	0.000326	CbGpPWpGaD
Furosemide—PGD—Disease—IRS1—osteoporosis	1.3e-05	0.000323	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TNF—osteoporosis	1.28e-05	0.000318	CbGpPWpGaD
Furosemide—CA12—Metabolism—ADCY5—osteoporosis	1.28e-05	0.000317	CbGpPWpGaD
Furosemide—CA12—Metabolism—GPX1—osteoporosis	1.28e-05	0.000316	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	1.27e-05	0.000315	CbGpPWpGaD
Furosemide—CA5B—Metabolism—MTHFR—osteoporosis	1.27e-05	0.000315	CbGpPWpGaD
Furosemide—CA7—Metabolism—MTHFR—osteoporosis	1.27e-05	0.000315	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.27e-05	0.000314	CbGpPWpGaD
Furosemide—CA9—Metabolism—ENO1—osteoporosis	1.26e-05	0.000313	CbGpPWpGaD
Furosemide—CA4—Metabolism—CYP19A1—osteoporosis	1.25e-05	0.00031	CbGpPWpGaD
Furosemide—CA9—Metabolism—PSMA2—osteoporosis	1.25e-05	0.000309	CbGpPWpGaD
Furosemide—CA9—Metabolism—PSMA5—osteoporosis	1.25e-05	0.000309	CbGpPWpGaD
Furosemide—PGD—Disease—IL6R—osteoporosis	1.22e-05	0.000303	CbGpPWpGaD
Furosemide—ALB—Hemostasis—RAP1A—osteoporosis	1.2e-05	0.000298	CbGpPWpGaD
Furosemide—CA2—Metabolism—CYP19A1—osteoporosis	1.2e-05	0.000297	CbGpPWpGaD
Furosemide—CA12—Metabolism—MTHFR—osteoporosis	1.18e-05	0.000292	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—TGFB1—osteoporosis	1.18e-05	0.000292	CbGpPWpGaD
Furosemide—CA1—Metabolism—CYP19A1—osteoporosis	1.15e-05	0.000285	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.15e-05	0.000284	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	1.12e-05	0.000278	CbGpPWpGaD
Furosemide—CA14—Metabolism—POMC—osteoporosis	1.12e-05	0.000277	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—IL6—osteoporosis	1.1e-05	0.000271	CbGpPWpGaD
Furosemide—ALB—Hemostasis—FGA—osteoporosis	1.09e-05	0.00027	CbGpPWpGaD
Furosemide—CA5A—Metabolism—POMC—osteoporosis	1.09e-05	0.00027	CbGpPWpGaD
Furosemide—CA6—Metabolism—POMC—osteoporosis	1.09e-05	0.00027	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.06e-05	0.000262	CbGpPWpGaD
Furosemide—PGD—Metabolism—POMC—osteoporosis	1.05e-05	0.00026	CbGpPWpGaD
Furosemide—ALB—Metabolism—PKM—osteoporosis	1.04e-05	0.000259	CbGpPWpGaD
Furosemide—ALB—Metabolism—FDPS—osteoporosis	1.04e-05	0.000259	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL6—osteoporosis	1.04e-05	0.000257	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.02e-05	0.000254	CbGpPWpGaD
Furosemide—CA4—Metabolism—ADCY5—osteoporosis	1.02e-05	0.000253	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—TNF—osteoporosis	1.02e-05	0.000253	CbGpPWpGaD
Furosemide—CA4—Metabolism—GPX1—osteoporosis	1.02e-05	0.000252	CbGpPWpGaD
Furosemide—CA5B—Metabolism—POMC—osteoporosis	1.02e-05	0.000252	CbGpPWpGaD
Furosemide—CA7—Metabolism—POMC—osteoporosis	1.02e-05	0.000252	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP19A1—osteoporosis	1.01e-05	0.00025	CbGpPWpGaD
Furosemide—ALB—Hemostasis—FGB—osteoporosis	9.92e-06	0.000246	CbGpPWpGaD
Furosemide—ALB—Metabolism—PGLS—osteoporosis	9.9e-06	0.000245	CbGpPWpGaD
Furosemide—ALB—Metabolism—GPD2—osteoporosis	9.9e-06	0.000245	CbGpPWpGaD
Furosemide—CA2—Metabolism—ADCY5—osteoporosis	9.8e-06	0.000243	CbGpPWpGaD
Furosemide—CA2—Metabolism—GPX1—osteoporosis	9.76e-06	0.000242	CbGpPWpGaD
Furosemide—CA12—Metabolism—POMC—osteoporosis	9.42e-06	0.000233	CbGpPWpGaD
Furosemide—CA4—Metabolism—MTHFR—osteoporosis	9.4e-06	0.000233	CbGpPWpGaD
Furosemide—CA1—Metabolism—ADCY5—osteoporosis	9.39e-06	0.000233	CbGpPWpGaD
Furosemide—CA1—Metabolism—GPX1—osteoporosis	9.36e-06	0.000232	CbGpPWpGaD
Furosemide—ALB—Metabolism—PNP—osteoporosis	9.06e-06	0.000224	CbGpPWpGaD
Furosemide—ALB—Metabolism—ATIC—osteoporosis	9.06e-06	0.000224	CbGpPWpGaD
Furosemide—CA2—Metabolism—MTHFR—osteoporosis	9.01e-06	0.000223	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	8.72e-06	0.000216	CbGpPWpGaD
Furosemide—CA1—Metabolism—MTHFR—osteoporosis	8.64e-06	0.000214	CbGpPWpGaD
Furosemide—CA9—Metabolism—ADCY5—osteoporosis	8.26e-06	0.000205	CbGpPWpGaD
Furosemide—CA9—Metabolism—GPX1—osteoporosis	8.23e-06	0.000204	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL6—osteoporosis	8.23e-06	0.000204	CbGpPWpGaD
Furosemide—ALB—Metabolism—CA2—osteoporosis	7.7e-06	0.000191	CbGpPWpGaD
Furosemide—ALB—Metabolism—OXCT1—osteoporosis	7.7e-06	0.000191	CbGpPWpGaD
Furosemide—CA9—Metabolism—MTHFR—osteoporosis	7.59e-06	0.000188	CbGpPWpGaD
Furosemide—CA4—Metabolism—POMC—osteoporosis	7.52e-06	0.000186	CbGpPWpGaD
Furosemide—ALB—Metabolism—MGLL—osteoporosis	7.5e-06	0.000186	CbGpPWpGaD
Furosemide—PGD—Disease—MYC—osteoporosis	7.26e-06	0.00018	CbGpPWpGaD
Furosemide—PGD—Disease—TGFB1—osteoporosis	7.24e-06	0.000179	CbGpPWpGaD
Furosemide—CA2—Metabolism—POMC—osteoporosis	7.21e-06	0.000179	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.08e-06	0.000175	CbGpPWpGaD
Furosemide—CA1—Metabolism—POMC—osteoporosis	6.91e-06	0.000171	CbGpPWpGaD
Furosemide—ALB—Metabolism—IDH2—osteoporosis	6.38e-06	0.000158	CbGpPWpGaD
Furosemide—CA9—Metabolism—POMC—osteoporosis	6.07e-06	0.00015	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP27A1—osteoporosis	6e-06	0.000149	CbGpPWpGaD
Furosemide—ALB—Metabolism—ACP5—osteoporosis	5.84e-06	0.000145	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.76e-06	0.000143	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.5e-06	0.000136	CbGpPWpGaD
Furosemide—PGD—Disease—IL6—osteoporosis	5.46e-06	0.000135	CbGpPWpGaD
Furosemide—ALB—Metabolism—TPI1—osteoporosis	5.43e-06	0.000134	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	5.23e-06	0.000129	CbGpPWpGaD
Furosemide—ALB—Metabolism—P4HB—osteoporosis	5.1e-06	0.000126	CbGpPWpGaD
Furosemide—ALB—Metabolism—GAPDH—osteoporosis	5.01e-06	0.000124	CbGpPWpGaD
Furosemide—ALB—Metabolism—RAP1A—osteoporosis	4.88e-06	0.000121	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IGF1—osteoporosis	4.49e-06	0.000111	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.25e-06	0.000105	CbGpPWpGaD
Furosemide—ALB—Metabolism—ENO1—osteoporosis	3.94e-06	9.77e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PSMA5—osteoporosis	3.88e-06	9.62e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PSMA2—osteoporosis	3.88e-06	9.62e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP19A1—osteoporosis	3.15e-06	7.81e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TGFB1—osteoporosis	2.69e-06	6.67e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ADCY5—osteoporosis	2.57e-06	6.38e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GPX1—osteoporosis	2.57e-06	6.36e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—MTHFR—osteoporosis	2.37e-06	5.87e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—POMC—osteoporosis	1.89e-06	4.69e-05	CbGpPWpGaD
